Family Medicine CME

Credits: 0.50 CME / MOC / NCPD
Medical Learning Institute, Inc.
Examining Novel Approaches to Improve the Management of Influenza: An Animated Exploration
Charles Vega, MD, FAAFP
July 21, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Determining Which Patients Will Benefit From GLP-1 RAs: Applying Guidelines and Evidence to Individualize Treatment Decisions in T2DM
Vanita R. Aroda, MD
July 16, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Demystifying the Role of Incretin-Based Weight-Loss Pharmacotherapy: A Patient-Centered Approach to Overcoming Barriers and Addressing Underlying Causes of Obesity
Donna H. Ryan, MD, FTOS
July 15, 2021
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Translating Science to Transform Clinical Practice: How MEK Inhibitors Are Changing the Treatment Landscape of NF1 and NF1-Associated Tumors
Bruce R. Korf, MD, PhD / Nicole J. Ullrich, MD, PhD, MMSci
July 15, 2021
Credits: 1.00 CME
Medical Learning Institute, Inc.
Going With Your Gut: Targeting Long-Term Weight Loss With Current and Emerging Incretin-Based Pharmacotherapy
Christopher D. Still, DO, FACP, FTOS / Alan C. Wittgrove, MD, FASMBS, FACS
July 7, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
The Dawn of a New Era: Recent Advances in the Pharmacologic Management of Idiopathic Hypersomnia
R. Robert Auger, MD, FAASM, FAPA, DABPN
June 25, 2021
Credits: 1.00 CME
Penn State College of Medicine
Management of Hyperlipidemia in the Family Medicine Setting: Diagnosis, Management, and the Role of Emerging Lipid-Lowering Therapies
James A. Underberg, MD, MS, FACPM, FACP, FNYAM, FASPC, FNLA
June 22, 2021
Credits: 1.00 CME
Medical Learning Institute, Inc.
Addressing the Unmet Needs of Patients With Moderate to Severe Psoriasis: A Visual Exploration of Disease Pathogenesis and the Clinical Potential of Targeting the TYK2 Pathway as a Novel Nonbiologic Oral Therapeutic Option
Andrew Blauvelt, MD, MBA
June 21, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Envisioning the Future of Emerging Nonfactor Therapies in Hemophilia A and B: The Art and Science of RNA Interference
Steven W. Pipe, MD
June 16, 2021
Credits: 1.25 CME / NCPD
Medical Learning Institute, Inc.
HIF-PH Inhibitors: An Emerging Strategy for Managing Anemia in Patients With Chronic Kidney Disease
Rajiv Agarwal, MD, MS
June 3, 2021
Credits: 1.50 CME
Medical Learning Institute, Inc.
Recognizing and Treating Hyperkalemia in Patients With Heart Failure and/or Chronic Kidney Disease: An Update for Hospitalists
George L. Bakris, MD
May 31, 2021
Credits: 1.00 CME / MOC / NCPD
Medical Learning Institute, Inc.
Advancing Care for People Living With Moderate to Severe Atopic Dermatitis: The Future Looks Clear
Jonathan I. Silverberg, MD, PhD, MPH / Eric Simpson, MD, MCR
May 26, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
The Evolving Role of Oxybate Agents in the Management of Narcolepsy: A Visual Exploration of Individualized Care
Richard K. Bogan, MD, FCCP, FAASM
May 18, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
A New Era of Migraine Management: Recent Updates on Recognition, Acute Treatment, and Prevention for Emergency Physicians
Benjamin W. Friedman, MD, MS, FAAEM, FACEP, FAHS
May 3, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Acute Hepatic Porphyria: Disease Diagnosis and Revelations Regarding the Role of siRNA Therapy
Karl E. Anderson, MD
April 15, 2021
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Addressing the Burden of Polyarticular Juvenile Idiopathic Arthritis: A Roadmap to Improving Early Diagnosis and Treatment to Maximize Long-Term Outcomes
Daniel J. Lovell, MD, MPH
April 8, 2021
Credits: 1.25 CME
Medical Learning Institute, Inc.
Partnering With Peers and Patients: Achieving T2DM Treatment Goals With GLP-1 RA Therapy
Jay H. Shubrook, DO, FAAFP, FACOFP
March 31, 2021
Credits: 0.50 CME / CPE
University of Florida College of Medicine / Medical Learning Institute, Inc.
New Insights: How Does Real-World Evidence Influence VTE Management? A Visual Exploration of Real-World Studies of DOACs
Alexander (Ander) Cohen, MB BS (Hons), MSc, MD, FRACP, FESC
March 23, 2021
Credits: 0.50 CME
Penn State College of Medicine
Test Your Knowledge: The Evidence for GABA-Modulating Neuroactive Steroids as a New Class of Rapid-Acting Antidepressants
Kristina M. Deligiannidis, MD
March 16, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
IL-17 Inhibitors in Nonradiographic Axial Spondyloarthritis: Expert Insight on Clinical Decision-Making in an Expanding Therapeutic Landscape
Philip J. Mease, MD, MACR
March 4, 2021
Credits: 1.50 CME / MOC / CE / CPE
The National Lipid Association
Mastering the Management of Hyperlipidemia in Statin-Treated or Statin-Intolerant Patients: Recent Treatment Advances for Patients That Remain at High Risk of ASCVD
Professor Kausik Ray
December 31, 2020
Credits: 1.00 CME / CPE
Medical Learning Institute, Inc.
Overcoming Challenges in the Diagnosis and Treatment of Invasive Fungal Infections: A Visual Guide for Clinicians on the Front Lines of Patient Care
Thomas F. Patterson, MD, FACP, FIDSA
December 29, 2020
Credits: 0.50 CME
Medical Learning Institute, Inc.
Navigating the Relationship Between Type 2 Inflammation and Uncontrolled, Moderate to Severe Asthma: Identifying Eligible Patients for Targeted Biologic Therapy
Professor Ian M. Adcock, PhD, FRSB, FBPhS, FERS
December 7, 2020
Credits: 0.50 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Understanding the Relationship Between Type 2 Inflammation, Atopic Diseases, and Treatment Selection: Practical Strategies for the Healthcare Team to Improve Patient Care
Jonathan A. Bernstein, MD
December 4, 2020
Credits: 1.00 CME
PeerView Institute
Improving Recognition of Nonvalvular Atrial Fibrillation to Reduce the Risk of Preventable Stroke: A Visual Guide for Clinicians
Sean Pokorney, MD, MBA
December 3, 2020
Credits: 1.00 CME
PeerView Institute
Advances in the Treatment of Alzheimer’s Disease: Preparing for a Shift in the Treatment Paradigm
Richard S. Isaacson, MD, FAAN
November 24, 2020
Credits: 1.00 CME
Joslin Diabetes Center
Highlighting the Vital Role of Primary Care in Identifying and Optimizing the Treatment of Diabetic Retinopathy and Diabetic Macular Edema
Andrew Moshfeghi, MD, MBA
November 18, 2020
Credits: 0.50 CME
Penn State College of Medicine
Show Me the Data: Improving Renal Outcomes With Glucose-Lowering Therapy in the Individualized Management of T2DM
George L. Bakris, MD
November 2, 2020
Credits: 1.00 CME
PeerView Institute
The Art of Medicine: Creating Treatment Regimens With GLP-1 RAs to Reduce Cardiovascular Risks in Patients With T2DM
Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC
October 28, 2020
Credits: 0.5 CME / CNE
Johns Hopkins University School of Medicine
Seeing the Importance of the Timely Recognition and Treatment of Diabetic Retinopathy and Diabetic Macular Edema
J. Fernando Arevalo, MD, PhD, FACS
October 28, 2020

Pages

Education Collections